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InductionBetaine uptake is induced by hypertonic stress in a placental trophoblast cell line, and involvement of amino acid
transport system A was proposed. Here, we aimed to identify the subtype(s) of system A that mediates
hypertonicity-induced betaine uptake. Measurement of [14C]betaine uptake by HEK293 cells transiently
transfected with human or rat sodium-coupled neutral amino acid transporters (SNATs), SNAT1, SNAT2 and
SNAT4 revealed that only human and rat SNAT2 have betaine uptake activity. The Michaelis constants (Km) of
betaine uptake by human and rat SNAT2 were estimated to be 5.3 mM and 4.6 mM, respectively. Betaine exclu-
sively inhibited the uptake activity of SNAT2 among the rat system A subtypes. We found that rat SNAT1, SNAT2
and SNAT4 were expressed at the mRNA level under isotonic conditions, while expression of SNAT2 and SNAT4
was induced by hypertonicity in TR-TBT 18d-1 cells. Western blot analyses revealed that SNAT2 expression on
plasmamembrane of TR-TBT 18d-1 cellswasmorepotently inducedbyhypertonicity than that in total cell lysate.
Immunocytochemistry conﬁrmed the induction of SNAT2 expression in TR-TBT 18d-1 cells exposed to hyperton-
ic conditions and indicated that SNAT2was localized on the plasmamembrane in these cells. Our results indicate
that SNAT2 transports betaine, and that tonicity-sensitive SNAT2 expression may be involved in regulation of
betaine concentration in placental trophoblasts.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Betaine is an organic osmolyte that contributes to cytoprotection
against osmotic stress. Its intracellular concentration is determined by
the balance of synthesis, degradation, and net transport across the cell
membrane. Betaine is highly hydrophilic and its plasma membrane
permeation is mainly mediated by transporter(s). To regulate the intra-
cellular osmolarity in response to extracellular hypertonicity, choline
dehydrogenase (the ﬁrst enzyme in the betaine biosynthetic pathway)
and betaine uptake transporters are up-regulated, while betaine homo-
cysteine S-methyltransferase, which metabolizes betaine, is down-
regulated in various cells, such as hepatic cells [1,2]. Tissue distribution
of betaine is not uniform, that is, its concentration in rats is quite high in
liver, kidney and placenta (7.2, 6.9 and 2.6–5 μmol/g, respectively), but
is less than 1.0 μmol/g in tissues such as pancreas, small intestine and
heart, and is undetectable in lung and brain [3–5]. Therefore betaine is
able to play more important role as an osmolyte in tissues where
betaine concentration is high.ights reserved.Betaine/GABA transporter (BGT-1, SLC6A12) is a well-characterized
betaine transporter that is driven by inward gradients of sodium and
chloride, in common with other SLC6A transport proteins. BGT-1 is
osmosensitive, and plays a role in regulation of intracellular osmolarity
via uptake of betaine from the extracellular ﬂuid, particularly in renal
cells [6]. Sodium/imino acid transporter 1 (SIT1, Slc6a20), which is
also driven by sodium and chloride gradients, transports both betaine
and proline [7]. SIT1 is also thought to be involved in osmoregulation
in mammalian oocytes [8], but it is unclear whether the expression of
SIT1 itself is regulated by changes of osmolarity. We have shown
that betaine uptake is induced by hypertonicity in TR-TBT 18d-1 cells
[9], which were used as a model for placental trophoblasts, but we
concluded that amino acid transport system A, rather than BGT-1, was
involved because the osmosensitive betaine uptake was inhibited by
2-(methylamino)isobutyric acid (MeAIB), a system A inhibitor and
that was not inhibited by 2 mM GABA. This is consistent with observa-
tions in SV-3T3 and hepatic stellate cells [10,11]. Therefore, it appears
that system A transporter(s) accepts betaine as a substrate and plays a
protective role in placenta against osmotic changes in maternal or
fetal plasma.
Among the sodium-coupled neutral amino acid transporters
(SNATs), SNAT1, SNAT2 and SNAT4 are system A neutral amino acid
1307T. Nishimura et al. / Biochimica et Biophysica Acta 1838 (2014) 1306–1312transporter subtypes, and these three subtypes of systemA have similar
substrate speciﬁcities, i.e., alanine, asparagine, cysteine, serine and
MeAIB are common substrates [12]. MeAIB is widely used as a speciﬁc
inhibitor for system A, and it inhibits all three subtypes. The three sub-
types are expressed in human placenta throughout gestation [13]. The
function of systemA is up-regulated by hypertonic stress inmammalian
cells [14], and SNAT2 and SNAT4 show osmosensitive induction of ex-
pression within 12 h of hypertonic treatment in TR-BBB cells [15].
However, the subtype(s) of system A responsible for betaine up-
take was not identiﬁed.
Here, we aimed to identify the systemA subtype(s) thatmediates be-
taine uptake and to clarify the molecular mechanism of osmosensitive
upregulation of betaine transport via system A [16].
2. Materials and methods
2.1. Chemicals
[Glycine-1-14C]N,N,N-trimethylglycine ([14C]betaine, 55 mCi/mmol)
was purchased from American Radiolabeled Chemicals, Inc. (St.
Louis, MO). [1-14C]Methylaminoisobutyric acid alpha ([14C]MeAIB,
58.8 mCi/mmol) was purchased from PerkinElmer Life and Analyti-
cal Sciences (Boston, MA). All other chemicals were commercial
products of analytical grade.
2.2. Cell culture
Culture of TR-TBT 18d-1 cells as a model for placental trophoblasts
was described previously [16]. Brieﬂy, the cells were grown at 33 °C in
Dulbecco's modiﬁed Eagle's medium (DMEM, 1.0 g/L glucose, Nacalai
Tesque, Kyoto, Japan) supplemented with 10% FBS (fetal bovine
serum, JRH Bioscience, Lenexa, KS), 2 mM L-glutamine, penicillin G
(100 units/mL), and streptomycin (100 μg/mL) in a humidiﬁed incuba-
tor under an atmosphere of 5% CO2 in air. TR-TBT 18d-1 cells were seed-
ed at the density of 1.0 × 105 cells/mL on porcine skin collagen type-I
coated 4-well plates. After 2 days of culture at 33 °C, the cells were fur-
ther cultured at 37 °C for 2 days and then used for gene expression
analyses and uptake studies with or without hypertonic stress.
HEK293 cells were maintained in DMEM (4.5 g/L glucose,
Nacalai Tesque) supplemented with 10% FBS (JRH Bioscience),
2 mM L-glutamine, penicillin G (100 units/mL), and streptomycin
(100 units/mL) at 37 °C in a humidiﬁed incubator under an atmosphere
of 5% CO2 in air.
2.3. Plasmid vectors containing a cDNA for human and rat SNAT1, SNAT2
and SNAT4
cDNA clones for hSNAT1/pCMV-SPORT6 (BC010620), hSNAT2/
pCMV-SPORT6 (BC040342), hSNAT4/pCR4-TOPO (BC101827), rSNAT1/
pExpressI (BC097283) and rSNAT4/pExpressI (BC097292) were com-
mercial products. hSNAT4 cDNAwas subcloned into pCMV-SPORT6 vec-
tor. rSNAT2 was cloned from TR-TBT 18d-1 cells by PCR and subcloned
into pExpressI vector. The cDNA sequence of the product was conﬁrmed
to be the same as that of the reference SNAT2 sequence (NM_181090).
pCMV-SPORT6 and pExpressI alone were used as negative controls in
the uptake studies for human and rat SNAT subtypes, respectively.
2.4. Functional characterization of SNAT1, SNAT2 and SNAT4 in HEK293
cells
HEK293 cells were seeded at the density of 1.0 × 106 cells/mL in a
100-mm dish and 12 μg of plasmid vector containing human or rat
SNAT1, SNAT2 or SNAT4 cDNA was transiently transfected using
Lipofectamine (Life Technologies Inc., Rockville, MD). At 40–48 h after
transfection, the cells were harvested and suspended in ECF buffer.
The uptake study was performed immediately, using the silicone layercentrifugationmethod. The cell suspensionwasmixedwith the solution
containing a radiolabeled test compound and then the cells in 200 μL of
the mixture were separated at a designated time by centrifugation at
10,000 g for 1 min through 100 μL of silicone layer (density of 1.03)
prepared by mixing silicone oil (1.065 g/mL, SH550, Dow Corning
Toray, Tokyo, Japan) and liquid parafﬁn (0.87 g/mL, Wako, Osaka,
Japan) into 50 μL of 3 N KOH solution in a 0.4 mL tube. Radioactivity
was measured with a liquid scintillation counter (LSC-6100, Hitachi-
AlokaMedical, Tokyo). Cellular protein contentwas determined accord-
ing to the Bradford's method using a BioRad protein assay kit (BioRad,
Hercules, CA) with bovine serum albumin (Pierce Biotechnology,
Rockford, IL) as a standard.
2.5. Kinetic analysis of betaine uptake by human and rat SNAT2
Initial uptake characteristics of betaine were kinetically analyzed by
mean of the following Michaelis–Menten type equation:
V ¼ Vmax  S
Km þ S
where V, Vmax, Km and S represent initial uptake velocity, maximum up-
take velocity, afﬁnity (Michaelis constant) and substrate concentration,
respectively. Data were ﬁtted to the equation by nonlinear regression
analysis using GraphPad Prism4 (GraphPad Software, San Diego, CA).
When the substrate concentration is much less than the Km value, the
equation can be approximated as:
V ¼ Vmax  S
Km
:
Then, Vmax/Km is given by initial uptake clearance V/S.
2.6. mRNA expression analyses for rat system A subtypes
Total RNA was isolated from TR-TBT 18d-1 cells cultured in isotonic
and hypertonic medium using an RNeasy mini kit (QIAGEN, Valencia,
CA). Reverse transcription was performed by using a High Capacity
RNA-to-cDNA kit (Life Technologies Inc.). The RT-PCR products ampliﬁed
by selective PCR primers (gtggagaacggccagataaa/ggtttccttggagcagatca
for rSNAT1, aaggcatacggtctggctgg/tatcggctgcggtgctgttg for rSNAT2, and
accctggaacgacctctttt/aaacgccttctctcccaact for rSNAT4) were visualized
after electrophoresis on 1% agarose in TAE (Tris–acetate–EDTA) buffer
(Nacalai Tesque), followed by ethidium bromide staining. Quantitative
RT-PCR was conducted with Power SYBR Green PCR Mater Mix
(Life Technologies Inc.) on a 7300 Real-Time PCR system (Life Technolo-
gies Inc.). Relative expression was calculated by the ΔΔCt method
and ß-actin ampliﬁed by the primers (tcatgaagtgtgacgttgacatccgt/
cctagaagcatttgcggtgcacgatg) was used as a control.
2.7. Western blot analysis
TR-TBT 18d-1 cells exposed for 8 h to culture medium adjusted at
300 or 500 mOsm/kg with sorbitol and Cos-7 cells transfected with
hSNAT2/pCMV-SPORT6 and vector alone were harvested by adding
cell lysis buffer (Cell Signaling Technology, Inc., Danvers, MA) supple-
mented with a complete protease inhibitor cocktail tablet (Roche Diag-
nostics, Basel, Switzerland). The samples were each homogenized by
pipetting and sonication, and the supernatants obtained by centrifuga-
tion at 14,000 g for 10 min were stored at−80 °C until use. For plasma
membrane fraction, the cells cultured in the isotonic and hypertonic
conditions described above were harvested by a cell scraper and
washed 3-times by phosphate-buffered saline (PBS). The cells were
centrifuged at 2000 g for 10 min, and the pellet was re-suspended in a
buffer containing 10 mM NaCl, 1.5 mM MgCl2, and 10 mM Tris
(pH 7.4), and then homogenized by nitrogen cavitation at 700 psi. The
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10 min. The supernatant was subjected to density-gradient centrifuga-
tion in 35% sucrose solution at 18,000 g for 90 min. The middle layer
was harvested and mixed with buffer containing 150 mM mannitol,
75 mM potassium gluconate, and 10 mMHEPES (pH 7.4). This fraction
was then ultracentrifuged at 100,000 g for 3 h and the pellet was re-
suspended in the last buffer. All the procedures were conducted at
4 °C. Protein concentrations were determined with a BCA protein
assay kit (Pierce Biotechnology). All samples were mixed with NuPAGE
LDS sample buffer and reducing agent (Invitrogen), followed by boiling
at 70 °C for 10 min. Proteins (10 μg for TR-TBT 18d-1 cell lysates and
30 μg for Cos-7 cell lysates) were separated by SDS-polyacrylamide
gel electrophoresis (7.5% polyacrylamide gel) and transferred onto a
polyvinylidene diﬂuoride membrane (Clear Blot Membrane-P,
ATTO, Tokyo, Japan). For detection of human and rat SNAT2 protein
and ß-actin, the membrane was incubated with 0.1% rabbit anti-
SLC38A2 antibody (Sigma-Aldrich, St. Louis, MO, HPA035180) or 0.02%
anti-ß-actin antibody (Sigma-Aldrich, Clone AC-15) in PBS containing
0.1% Tween 20 and 3% skim milk. The membranes were rinsed with
PBS containing 0.1% Tween 20, and reacted with horseradish
peroxidase-conjugated anti-rabbit or anti-mouse IgG. Bands were visu-
alized using an enhanced chemiluminescence detection method with
ECL Western blotting detection kit (GE Healthcare, Chalfont St. Giles,
Buckinghamshire, UK).
2.8. Immunocytochemistry
TR-TBT 18d-1 cells were cultured on collagen-coated cover glass at
33 °C for 2 days and at 37 °C for a further 2 days. The cellswere exposed
to DMEM supplemented with 200 mM sorbitol for another 8 h (hyper-
tonic condition), and then ﬁxed with 4% paraformaldehyde in 0.1 M
phosphate buffer at 4 °C for 30 min. The ﬁxed cells were permeabilized
with 0.1% Triton-X 100 in PBS and treatedwith protein blocking reagent
(DAKO, Carpinteria, CA) at room temperature for 1 h. Next, the cells
were incubated with 3% rabbit anti-SLC38A2 antibody (Sigma-Aldrich,
HPA035180) at room temperature for 2 h and subsequently with
Alexa Fluor 594 anti-rabbit IgG (Invitrogen) at room temperature for
1 h, followed by mounting using VECTASHIELD Hard Set Mounting
Medium with DAPI (Vector Laboratories, Burlingame, CA). Microscopic
images were captured with a confocal laser-scanning microscope
(FV1000D, Olympus, Tokyo, Japan).
2.9. Statistics
The statistical signiﬁcance of differences was calculated by using
Student's t test or analysis of variance (ANOVA) with Dunnett's post-
hoc test for multiple comparisons. A p value of less than 0.05 was
regarded as signiﬁcant.
3. Results
3.1. Betaine uptake by amino acid transport system A subtypes
The three system A subtypes, SNAT1, 2, and 4, were each transiently
expressed in HEK293 cells, and uptakes of [14C]betaine and [14C]MeAIB
by the cells were measured. Only human and rat SNAT2 showed
signiﬁcant [14C]betaine uptake (Fig. 1a,c), while all three subtypes
showed [14C]MeAIB uptake activity (Fig. 1b,d). These results indicated
that SNAT2 mediates betaine uptake, while the other subtypes do not.
To compare the uptake activity between substrates, the initial uptake
velocities of betaine and MeAIB at 5 min were divided by their concen-
tration (4.5 μM and 8.5 μM, respectively) and the uptake clearance
(Vmax/Km) values were estimated to be 140 and 48 μL/mg protein/
5 min, respectively. Initial uptake clearance of betaine was greater
than that of MeAIB. To further characterize the betaine uptake activity
of human and rat SNAT2, we analyzed concentration-dependentbetaine uptake in terms of Michaelis–Menten type kinetics using the
equation given in the Materials andmethods (Fig. 2a,c). Saturable beta-
ine uptake via human and rat SNAT2 gave linear Eadie–Hofstee plots
(Fig. 2b,d). The values of uptake afﬁnity (Km) and maximum uptake ve-
locity (Vmax) of betaine for human and rat SNAT2 were calculated to be
5.3 ± 1.1 mM and 381 nmol/mg protein/5 min, while those for rat
were 4.6 ± 0.8 mM and 773 nmol/mg protein/5 min. The inhibitory
effect of betaine on SNAT-mediated uptake was examined using [14C]
MeAIB as a substrate. Rat SNAT1 and SNAT4-mediated [14C]MeAIB up-
take was hardly inhibited by betaine, but rat SNAT2-mediated [14C]
MeAIB uptake was almost completely inhibited by 10 mM betaine
(Fig. 3).
3.2. Inducibility of system A subtypes by hypertonicity in rat placental
trophoblast TR-TBT 18d-1 cells
To identify the subtype of system A responsible for hypertonicity-
induced betaine uptake in TR-TBT 18d-1 cells, mRNA expression of sys-
tem A subtypes was measured. All three subtypes of system A were
expressed under isotonic conditions (DMEM), though the expression
of SNAT4 was less than that of SNAT1 and SNAT2 (Fig. 4a). SNAT2 and
SNAT4 were induced by hypertonicity (DMEM with 200 mM sorbitol),
while SNAT1 showed little change (Fig. 4b). To investigate the effects
of amino acids on the SNAT2 induction, TR-TBT 18d-1 cells were cul-
tured under the hypertonic condition in thepresenceof taurine, betaine,
MeAIB and arginine, but little effect on SNAT2 mRNA was observed
(Supplementary Fig. S1).
To verify that SNAT2 expression is induced by hypertonicity in TR-
TBT 18d-1 cells, protein expression of SNAT2 in cell lysate and mem-
brane fraction was analyzed by Western blotting and immunocyto-
chemistry. Rat SNAT2 induced by hypertonic treatment showed a
band of similar size to hSNAT2 (Fig. 5a). Densitometric analysis of the
60–75 kDa region indicated that SNAT2 protein expression in cell lysate
and cell membrane was increased 5.4-fold and 35-fold, respectively,
under the hypertonic condition (Fig. 5b). The fraction of SNAT2 local-
ized on cell membrane was evaluated as relative protein expression in
cell membrane to that in lysate, and under the hypertonic condition
this fraction was 6.3-fold higher than that under isotonic conditions
(Fig. 5c). Human and rat SNAT2 bands were expressed in a slightly
higher molecular weight area than would be expected from the amino
acid sequence, in agreement with previous reports [17,18]. SNAT2 was
localized intracellularly in TR-TBT 18d-1 cells under isotonic conditions
(Fig. 6a). However, expression of SNAT2 was markedly induced by hy-
pertonicity, and in the induced cells, SNAT2 staining was observed at
the cell membrane (Fig. 6b).
4. Discussion
Betaine transport across the plasma membrane is induced in re-
sponse to hypertonic stress in renal and placental cells [9,19], and
BGT-1 is the best-characterized betaine transporter. Betaine uptake is
also mediated by system A [9–11], but the subtype(s) involved was
not established. The present results show that SNAT2 transports beta-
ine, while the other two subtypes, SNAT1 and SNAT4, do not (Fig. 1a,
c). Both human and rat SNAT2 showed betaine uptake activity and
there was no marked difference in their kinetic characteristics (Fig. 2).
These results suggest that betaine uptake by SNAT2 is well conserved,
at least in rat and human, and SNAT2 has a physiological role in regulat-
ing betaine concentration, at least in certain types of cells.
The substrate speciﬁcity of all system A subtypes has been believed
to be similar. For instance, alanine, asparagine, serine and MeAIB are
common substrates [12]. This similarity has hindered characterization
of the roles of individual system A subtypes in cases where plural
subtypes are expressed in the same tissue. However, among system
A subtypes, only SNAT4 transports cationic amino acids and therefore
L-arginine-inhibitable MeAIB uptake represents SNAT4 function
Fig. 1. Identiﬁcation of system A subtype(s) involved in betaine uptake. HEK293 cells were transiently transfected with a plasmid vector containing human (a,b) or rat (c,d) SNAT1 (●),
SNAT2 (○) or SNAT4 (◊) cDNA andwith vector alone as a negative control (MOCK, Δ). [14C]Betaine (4.5 μM) uptake wasmeasured at 37 °C for 10 min (a,c). [14C]MeAIB (8.5 μM) uptake
wasmeasured as a positive control (b,d). Data are presented asmean ± S.E.M. (n = 3–4). Asterisk (*) indicates statistical signiﬁcance with a p value of less than 0.05 when compared to
the uptake by MOCK cells.
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speciﬁc to SNAT2, and can therefore be used to distinguish this
subtype from the others. Thus, the individual functions of the system
A subtypes can be distinguished by using betaine and L-arginine as
inhibitors.
The Michaelis constants of human and rat SNAT2 for betaine
(approximately 5 mM; Fig. 2) aremuch higher than the reported values
for BGT-1 (200–400 μM) and SIT1 (0.2 mM) [7,25]. Considering that the
plasma betaine concentration is around 35–50 μM in humans and
100–200 μM in rats [26–28], the transport afﬁnity of SNAT2 for betaine
seems low. However, we consider that it would be physiologically
relevant, since low afﬁnity compared with the physiological concentra-
tionmeans that the transport would not easily become saturated under
conditions where the betaine concentration varies substantially.
Further, the capacity of SNAT2 would be partly taken up by other
substrates due to its multiple substrate recognition characteristic. Initial
uptake clearance of betaine by rat SNAT2 was at least greater than that
of MeAIB.
Amino acid transport system A is known to be induced by amino
acid depletion. Induction of SNAT2 expression by amino acid depletion
is mitigated by the presence of taurine, betaine or MeAIB via ATF4
transcriptional factor [29]. To characterize the hypertonicity-induced
SNAT2 expression in placental trophoblasts, we measured the effect of
these amino acids on the SNAT2 induction. However, these amino
acids did not inhibit SNAT2 induction in the concentration range up to
1000 μM (Supplementary Fig. S1). These results indicated that the
mechanism of SNAT2 induction by the hypertonic condition is different
from that of the induction by amino acid depletion.SNAT2 was induced at both the mRNA and protein levels by hyper-
tonicity in TR-TBT 18d-1 cells, but the induction of SNAT2 protein was
much greater than would be expected from the mRNA induction
(Figs. 4b, 5b). Functional upregulation of SNAT2 would be consistent
with a previous report that showed enhancement of MeAIB-sensitive
[14C]betaine uptake in TR-TBT 18d-1 cells under hypertonic condi-
tions [9]. Hypertonicity activates TonEBP, which enhances target gene
expression by binding to TonE sites in the 5′-ﬂanking region from the
transcriptional start point. Mice lacking TonEBP showed normal growth
at embryonic day 14.5, but 50% of the mice died before birth [30], indi-
cating that osmoregulation is important for normal growth, especially in
the late stage of gestation. Although BGT-1 has at least two TonE sites,
which may contribute to the induction of BGT-1 by hypertonicity
[31,32], there do not appear to be any TonE sites located in the upstream
1 kbp region from the transcription start site of human and rat SNAT2.
Nevertheless, SNAT2 was more inducible than BGT-1 by hypertonicity
in placental trophoblasts [9]. Themechanism of SNAT2 induction by hy-
pertonicity remains uncertain. The effect of TonEBP on osmolarity-
inducible SNAT2 expression should be clariﬁed in the future.
SNAT2 was expressed even under isotonic conditions, and appeared
to be localized primarily in an intracellular compartment (Fig. 6a).
However, when SNAT2 was induced under hypertonic conditions, it
was localized on the cell membrane, as well as intracellularly (Figs. 5,
6b). These results indicate that SNAT2 was regulated by tonicity
at both the post-transcriptional and transcriptional levels. These
observations are consistent at least in part with the previous report
that SNAT2 is expressed in the intracellular compartment, as well as
the cell membrane in ﬁbroblasts and the microvillous membrane, in
Fig. 2. Kinetics of betaine transport by human and rat SNAT2. HEK293 cells were transiently transfected with plasmid vector containing human (a,b) or rat (c,d) SNAT2 cDNA, or with
vector alone. Uptake of [14C]betaine (4.5 μM)was examined in the presence of unlabeled betaine at concentrations up to 12.5 mM. Betaine uptake via hSNAT2 or rSNAT2 was calculated
by subtracting the uptake in vector alone-transfected HEK293 cells from that in HEK293 cells expressing human or rat SNAT2. The hSNAT2 and rSNAT2-mediated betaine uptakes were
analyzed on the basis of Michaelis–Menten type kinetics (a,c) and with Eadie–Hofstee plots (b,d). Data are presented as mean ± S.E.M. (n = 4).
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sis mainly contributes to the hypertonicity-induced functional expres-
sion of SNAT2 in ﬁbroblasts [33]. In our study, protein synthesis andFig. 3. Inhibitory effect of betaine on rat SNAT-mediated uptake of MeAIB. HEK293 cells
were transiently transfected with plasmid vector containing rat SNAT1, SNAT2 or SNAT4
cDNA, or with vector alone. Uptake of [14C]MeAIB (8.5 μM)was examined in the presence
of unlabeled betaine at concentrations up to 10 mM. [14C]MeAIB uptake via rSNAT2 was
calculated by subtracting the uptake in HEK293 cells transfected with the vector alone
from that in HEK293 cells expressing rat SNAT2. rSNAT-mediated [14C]MeAIB uptake
was normalized by the corresponding uptake in the absence of unlabeled betaine (control
uptake). Data are presented as mean ± S.E.M. (n = 4). Asterisk (*) indicates statistical
signiﬁcance with a p value of less than 0.05 when compared to control uptake (open col-
umn), using ANOVA with Dunnett's post-hoc test.
Fig. 4. Expression of systemA subtypes and their response to hypertonicity in TR-TBT 18d-1
cells. Expression of rat systemA subtypes (SNAT1, SNAT2 and SNAT4)wasmeasured in TR-
TBT18d-1 cells cultured under isotonic conditions (a). PCR productswith reverse transcrip-
tion (RT) and without RT (negative control) were analyzed by electrophoresis. Each PCR
product showed a single band, and no signiﬁcant band of PCR product was observed with-
out RT. The effect of hypertonic culture on expression of rat system A subtypes in TR-TBT
18d-1 cells was also examined (b). Quantitative RT-PCR was performed using TR-TBT
18d-1 cells incubated for 8 h under isotonic (300 mOsm/kg, open column) and hypertonic
(500 mOsm/kg, closed column) conditions. Data are presented as mean ± S.E.M.
(n = 3–4). Asterisk (*) indicates statistical signiﬁcance with a p value of less than 0.05
when compared to the corresponding expression in isotonic culture (open column).
Fig. 5. Upregulation of rat SNAT2 protein by hypertonicity in TR-TBT 18d-1 cells. TR-TBT 18d-1 cells were incubated at 37 °C in isotonic or hypertonic medium for 8 h. Rat SNAT2 expres-
sion in total cell lysate andplasmamembrane fractionwas analyzed byWestern blotting. 10 μg protein of cell lysate ormembrane fractionwas applied in each lane. Transient expression of
human SNAT2 in Cos-7 cells and representative results of detection of rat SNAT2 in TR-TBT 18d-1 cells are shown in (a) and band intensities in 60–75 kDa of rat SNAT2 quantiﬁed by
densitometry are shown in (b). Data are presented mean ± S.E.M. (n = 3). Asterisk (*) indicates statistical signiﬁcance with a p value of less than 0.05.
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hypertonicity-induced plasma membrane expression of SNAT2 (Fig. 5),
indicating that contributions of protein synthesis and translocation to
plasma membrane expression depend on cell types. Post-transcriptional
regulation of SNAT2 has been investigated. SNAT2 is stored in the trans-
Golgi network in 3T3-L1 adipocytes, and is released to the plasma mem-
brane upon stimulation with insulin [34]. Inhibition of mTOR decreased
microvillous membrane expression of SNAT2 [35,36]. Thus, the function
of SNAT2 is dynamically regulated both post-transcriptionally and
transcriptionally.
The existence of post-transcriptional regulation of SNAT2 protein lo-
calization (Fig. 6) implies that the uptake activity of SNAT2would be rap-
idly increased in response to hypertonicity. As regards the transcriptional
regulation, the induction of SNAT2 mRNA reached the peak withinFig. 6. Immunocytochemical analysis of upregulation of SNAT2 induced by exposure of TR-TBT 1
by DAPI (4′,6-diamidino-2-phenylindole, blue) in rat placental TR-TBT 18d-1 cells are shown. T
tonic (b, 500mOsm/kg)medium. Fixed cells were incubatedwith primary antibody (anti-SLC38
then incubated with Alexa594-conjugated secondary antibody for 1 h at room temperature. Im
the lines indicated are presented below and on the right of the confocal image. Wavelengths
Bars = 10 μm.3–6 h, and thendeclined almost to the original levelwithin 24 h in endo-
thelial cells treated with hypertonic medium adjusted to 0.5 osmol/kg
[37]. Expression of TauT and BGT-1 is induced more slowly, peaking at
17 and 24 h, respectively [38,39], possibly to compensate for the de-
crease of system A after its transient induction. Therefore, SNAT2 may
have a role in acute osmolyte regulation in response to extracellular
osmotic changes.
In conclusion, our results indicate that only SNAT2 among the sys-
tem A subtypes has betaine transport activity. The involvement of
SNAT2 in betaine uptake by the placental trophoblasts may contribute
to cytoprotection in response to osmotic stress arising from differences
in osmolality between the maternal and fetal circulations. The rapid
induction and high capacity of SNAT2 for betaine transport may be
important in ensuring a robust response to acute osmotic changes.8d-1 cells to hypertonicity. Immunostaining of rat SNAT2 (red) and nuclear staining (blue)
R-TBT 18d-1 cells were incubated at 37 °C for 8 h in isotonic (a, 300 mOsm/kg) or hyper-
A2 rabbit polyclonal IgG) diluted to 3% in blocking buffer for 2 h at room temperature and
ages were acquired using confocal laser scanningmicroscopy. Cross-sectional views along
for excitation and emission were 559 nm and 618 nm, respectively. Magniﬁcation ×600.
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